查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區放射性示踪劑市場預測至 2030 年 - 區域分析 - 按示踪劑類型、測試類型、應用和最終用戶
市場調查報告書
商品編碼
1420148

亞太地區放射性示踪劑市場預測至 2030 年 - 區域分析 - 按示踪劑類型、測試類型、應用和最終用戶

Asia Pacific Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 135 Pages | 訂單完成後即時交付

價格

2022年亞太地區放射性示蹤劑市值為16.158億美元，預計2030年將達66.2961億美元；預計2022年至2030年CAGR為19.3%。

慢性病盛行率上升推動亞太地區放射性示蹤劑市場

人口老化的加劇、社會行為的改變、久坐生活方式的增加以及城市化進程的加速是導致肥胖和糖尿病等其他慢性病盛行率的關鍵因素。此外，研究早已證實基因可導致心血管疾病（CVD）、糖尿病、肥胖、阿茲海默症（AD）和憂鬱症等慢性疾病。

忙碌的生活方式引起的動脈粥狀硬化、心絞痛、急性心肌梗塞等心血管疾病已成為全球死亡的重要原因。根據世界衛生組織提供的資料，心血管疾病是全世界死亡的主要原因，每年估計有 1,790 萬人死亡。糖尿病是一種危及生命的慢性疾病，無法進行功能性治癒。所有類型的糖尿病都會導致身體不同部位出現各種併發症，並增加過早死亡的整體風險。心臟病、中風、腎衰竭、截肢、視力喪失和神經損傷是與糖尿病相關的主要併發症。在預測期內，該疾病的盛行率可能會增加近 35%。

因此，有效的檢查是正確治療慢性病的必要條件；因此，核物質被用於診斷和檢查目的。這些核物質用於正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT）等診斷測試，以診斷神經系統疾病、心血管疾病、慢性肺部疾病和慢性腎臟病等慢性疾病。全球範圍內有多種放射性示蹤劑可供使用，因此可以根據疾病類型及其預後輕鬆進行選擇。因此，慢性病發病率的增加導致對放射性示蹤劑的需求激增，積極有利於市場擴張。

亞太地區放射性示蹤劑市場概況

亞太地區放射性示蹤劑市場分為澳洲、中國、印度、日本、韓國和亞太其他地區。由於新研究設施的發展、老年人口的增加以及混合系統隨著領域技術進步的顯著發展等因素，該地區的市場在預測期內可能會繼續以最快的速度成長。

亞太地區放射性示蹤劑市場收入及 2030 年預測（百萬美元）

亞太地區放射性示蹤劑市場細分

亞太地區放射性示踪劑市場根據示踪劑類型、測試類型、最終用戶、應用和國家進行細分。根據示蹤劑類型，亞太地區放射性示蹤劑市場分為锝-99m和Tc-97m、碘-131、鐵-59、鏑-171、銣（Rb-82）氯化物和氨（N-13） 、鈧-46、seaborgium-269、hassium-269、檸檬酸鎵Ga 67、前列腺特異性膜抗原(PSMA) (Ga-68)、FDDNP (F-18) 和FDOPA (F-18)、磷-32和鉻- 51、鉈-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE (Ga-68) 等。 2022 年，其他細分市場佔據最大市場佔有率。

根據測試類型，亞太地區放射性追蹤劑市場分為 PET、SPECT 等。 SPECT 細分市場在 2022 年佔據最大的市場佔有率。

根據最終用戶，亞太地區放射性示蹤劑市場分為醫院和診所、診斷中心、學術和研究機構等。 2022 年，醫院和診所細分市場佔據最大的市場。

根據應用，亞太地區放射性示蹤劑市場分為腫瘤學、肺病學、神經病學、心臟病學等。 2022 年，腫瘤學領域佔據最大的市場。

依國家/地區分類，亞太地區放射性示蹤劑市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國在亞太地區放射性示蹤劑市場佔有率中佔據主導地位。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、紐卡斯爾大學、諾華公司、Curium 和 IBA Radiopharma Solutions 是亞太地區放射性示踪劑市場的一些領先參與者。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區放射性示蹤劑市場 - 主要產業動態

  • 主要市場促進因素：
    • 慢性病盛行率上升
    • 擴大使用核子成像技術
  • 市場限制
    • 放射性示蹤劑的保存期限短
    • 核診斷影像程序替代品的可用性
  • 市場機會
    • 新興經濟體的存在與人口的成長
    • 用於標靶治療的個人化放射性藥物的開發
  • 未來的趨勢
    • 放射性示蹤劑在癌症診斷的應用
  • 影響分析：

第 5 章：放射性示蹤劑市場 - 亞太地區市場分析

  • 放射性示蹤劑市場收入，2022 - 2030

第 6 章：亞太地區放射性示蹤劑市場 - 收入和 2030 年預測 - 按示蹤劑類型

  • 概述
  • 2022 年及 2030 年放射性示蹤劑市場收入佔有率，依示蹤劑類型分類 (%)
  • 锝 99m 和 TC-97m
  • 碘131
  • 鐵59
  • 镥- 171
  • RB82和氨N-13
  • 鈧46
  • ?-269
  • 哈西姆-269
  • 檸檬酸鎵 GA 67
  • PSMA GA68
  • FDDNP (F-18) 和 FDOPA (f-18)
  • 磷 32 和鉻 -51
  • 鉈201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE Ga 68
  • 其他

第 7 章：亞太地區放射性示蹤劑市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年按測試類型分類的放射性示蹤劑市場收入佔有率 (%)
  • 寵物
  • SPECT
  • 其他

第 8 章：亞太地區放射性示蹤劑市場 - 收入和 2030 年預測 -按應用。

  • 概述
  • 2022 年和 2030 年按應用分類的放射性示蹤劑市場收入佔有率 (%)
  • 腫瘤學
  • 肺部
  • 神經病學
  • 心臟病學
  • 其他

第 9 章：亞太地區放射性示蹤劑市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年及 2030 年最終用戶放射性示蹤劑市場收入佔有率 (%)
  • 醫院和診所
  • 診斷中心
  • 學術及研究機構
  • 其他

第 10 章：亞太地區放射性示蹤劑市場 - 國家分析

    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 11 章：放射性示蹤劑市場產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：放射性示蹤劑市場，主要公司概況

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • General Electric Co
  • IBA Radiopharma Solutions

第 13 章：附錄

  • 關於我們
  • 專業術語
Product Code: BMIRE00029110

The Asia Pacific radioactive tracer market was valued at US$ 1,615.80 million in 2022 and is expected to reach US$ 6,629.61 million by 2030; it is estimated to grow at a CAGR of 19.3% from 2022 to 2030.

Rising Prevalence of Chronic Diseases fuel the Asia Pacific Radioactive Tracer Market

Increasing aging population, changing social behavior, rising adoption of a sedentary lifestyle, and accelerating urbanization are the key factors boosting the prevalence of obesity and other chronic diseases such as diabetes. Further, studies have long established that genes can cause chronic conditions such as cardiovascular disease (CVD), diabetes, obesity, Alzheimer's disease (AD), and depression.

CVDs, such as atherosclerosis, angina pectoris, and acute myocardial infarction, caused due to hectic lifestyles have become significant causes of mortality worldwide. As per the data provided by the WHO, CVDs are the predominant cause of death worldwide, recording estimated 17.9 million deaths each year. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes. The disease prevalence will likely increase by nearly 35% during the forecast period.

Thus, an effective examination is a must for properly treating chronic diseases; hence, nuclear substances are used for diagnosis and examination purposes. These nuclear substances are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) to diagnose chronic diseases such as neurological, cardiovascular, chronic lung, and chronic kidney diseases. the availability of several radiotracer across the globe makes it selection easy depending on the type of disease and its prognosis. Thus, the increasing incidences of chronic diseases are surging the demand for radioactive tracer, positively favoring market expansion.

Asia Pacific Radioactive Tracer Market Overview

The Asia Pacific radioactive tracer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as the development of new research facilities, the rise in the geriatric population and significant evolution of hybrid systems with technological advancement in the field of imaging.

Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Radioactive Tracer Market Segmentation

The Asia Pacific radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Asia Pacific radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the Asia Pacific radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the Asia Pacific radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the Asia Pacific radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the Asia Pacific radioactive tracer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the Asia Pacific radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Presence of Emerging Economies and Growing Population
    • 4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - Asia Pacific Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Radioactive Tracer Market - Country Analysis

  • 10.1 Asia Pacific Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Radioactive Tracer Market by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 China Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 China Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 China Radioactive Tracer Market, by Application
        • 10.1.2.1.6 China Radioactive Tracer Market, by End-User
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Japan Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Japan Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Japan Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Japan Radioactive Tracer Market, by End-User
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 India Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 India Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 India Radioactive Tracer Market, by Application
        • 10.1.2.3.6 India Radioactive Tracer Market, by End-User
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.3 Australia Radioactive Tracer Market, by Tracer Types
        • 10.1.2.4.4 Australia Radioactive Tracer Market, by Test Type
        • 10.1.2.4.5 Australia Radioactive Tracer Market, by Application
        • 10.1.2.4.6 Australia Radioactive Tracer Market, by End-User
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 South Korea Radioactive Tracer Market, by Tracer Type
        • 10.1.2.5.4 South Korea Radioactive Tracer Market, by Test Type
        • 10.1.2.5.5 South Korea Radioactive Tracer Market, by Application
        • 10.1.2.5.6 South Korea Radioactive Tracer Market, by End-User
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Asia Pacific Radioactive Tracer Market, by Tracer Types
        • 10.1.2.6.4 Rest of Asia Pacific Radioactive Tracer Market, by Test Type
        • 10.1.2.6.5 Rest of Asia Pacific Radioactive Tracer Market, by Application
        • 10.1.2.6.6 Rest of Asia Pacific Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 General Electric Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 IBA Radiopharma Solutions
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 11. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 16. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 17. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 18. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 19. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Type
  • Table 20. South Korea Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 21. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 22. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 23. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 24. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 25. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 26. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 27. Organic Developments Done by Companies
  • Table 28. Inorganic Developments Done by Companies
  • Table 29. Glossary of Terms, Asia Pacific Radioactive Tracer Market

List Of Figures

  • Figure 1. Asia Pacific Radioactive Tracer Market Segmentation, By Country
  • Figure 2. Asia Pacific Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Asia Pacific Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Asia Pacific Radioactive Tracer Market, By Country, 2022 ($Mn)
  • Figure 41. Asia Pacific Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)